Clinical
Trials
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
-
https://clinicaltrials.gov/ct2/show/NCT05267054
Condition:
Lymphoma
Molecule:Tislelizumab + Ociperlimab
-
https://clinicaltrials.gov/ct2/show/NCT05294731
Condition:
B-cell Malignancies
Molecule:BGB-11417
-
https://clinicaltrials.gov/ct2/show/NCT05100862
Condition:
Molecule:Zanubrutinib
-
https://clinicaltrials.gov/ct2/show/NCT05068440
Condition:
Molecule:Zanubrutinib
-
https://clinicaltrials.gov/ct2/show/NCT05014815
Condition:
Molecule:Tislelizumab + Ociperlimab
-
https://clinicaltrials.gov/ct2/show/NCT05116085
Condition:
Molecule:Tislelizumab
-
Treatment of Relapsed/Refractory Multiple Myeloma With t 11;14 Translocation Using BGB-11417 With Dexamethasone; Also Using BGB-11417 in Combination With Dexamethasone and Carfilzomib.
Condition:
Myeloma
Molecule:BGB-11417
-
Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults
Condition:
Tumor
Molecule:Sitravatinib
-
A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma (ROSEWOOD)
Condition:
Lymphoma
Molecule:Zanubrutinib
-
Study Comparing Zanubrutinib + Rituximab Versus Bendamustine + Rituximab in Participants With Untreated Mantle Cell Lymphoma
Condition:
Lymphoma
Molecule:Zanubrutinib
See All Trials
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.
This list includes trials with the following recruitment statuses: recruiting, enrolling by invitation, study start-up, not yet recruiting, and active/not recruiting.